4//SEC Filing
KERYX BIOPHARMACEUTICALS INC 4
Accession 0000899243-17-007645
CIK 0001114220operating
Filed
Mar 14, 8:00 PM ET
Accepted
Mar 15, 6:26 PM ET
Size
7.6 KB
Accession
0000899243-17-007645
Insider Transaction Report
Form 4
Madison Greg
See Remarks
Transactions
- Award
Common Stock
2017-02-14+150,000→ 383,711 total - Award
Employee Stock Option (Right to Buy)
2017-02-14+300,000→ 300,000 totalExercise: $5.53From: 2018-02-14Exp: 2027-02-14→ Common Stock (300,000 underlying)
Footnotes (3)
- [F1]The 150,000 shares are restricted common stock, with one-third of the 150,000 shares vesting on February 14, 2018 and one-twelfth vesting on each of May 14, 2018, August 14, 2018, November 14, 2018, February 14, 2019, May 14, 2019, August 14, 2019, November 14, 2019 and February 14, 2020.
- [F2]Includes 263,790 shares of restricted stock.
- [F3]The options vest according to the following schedule: one-third of the 300,000 options will vest on February 14, 2018 and one-twelfth will vest on each of May 14, 2018, August 14, 2018, November 14, 2018, February 14, 2019, May 14, 2019, August 14, 2019, November 14, 2019 and February 14, 2020.
Documents
Issuer
KERYX BIOPHARMACEUTICALS INC
CIK 0001114220
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001114220
Filing Metadata
- Form type
- 4
- Filed
- Mar 14, 8:00 PM ET
- Accepted
- Mar 15, 6:26 PM ET
- Size
- 7.6 KB